Idexx Laboratories (IDXX) Market Capitalization (2009 - 2026)

Idexx Laboratories has reported Market Capitalization for 18 years, with the latest figure at $41.5 billion in Q2 2026.

• On a quarterly basis, Market Capitalization fell 3.41% year-over-year to $41.5 billion in Q2 2026; TTM through Jun 2026 was $41.5 billion, a 3.41% decrease from a year earlier, with the FY2025 full-year figure at $53.9 billion, up 59.84% from the prior year.
• Market Capitalization was $41.5 billion for Q2 2026 at Idexx Laboratories, down from $44.5 billion in the prior quarter.
• The five-year high for Market Capitalization was $53.9 billion in Q4 2025, with the low at $27.0 billion in Q3 2022.
• Average Market Capitalization over 5 years is $40.5 billion, with a median of $41.5 billion recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Market Capitalization tumbled 48.78% in 2022, then soared 59.84% in 2025.
• Over 5 years, Market Capitalization stood at $33.8 billion in 2022, then soared by 36.28% to $46.1 billion in 2023, then decreased by 26.79% to $33.7 billion in 2024, then soared by 59.84% to $53.9 billion in 2025, then retreated by 23.0% to $41.5 billion in 2026.
• The last three Market Capitalization figures came in at $41.5 billion (Q2 2026), $44.5 billion (Q1 2026), and $53.9 billion (Q4 2025), per Business Quant data.